508 related articles for article (PubMed ID: 27697545)
1. Antivirals against animal viruses.
Villa TG; Feijoo-Siota L; Rama JLR; Ageitos JM
Biochem Pharmacol; 2017 Jun; 133():97-116. PubMed ID: 27697545
[TBL] [Abstract][Full Text] [Related]
2. Antivirals of ethnomedicinal origin: structure-activity relationship and scope.
Chattopadhyay D; Naik TN
Mini Rev Med Chem; 2007 Mar; 7(3):275-301. PubMed ID: 17346219
[TBL] [Abstract][Full Text] [Related]
3. Antiphage activity of natural and synthetic substances: a new age for antivirals?
Ribeiro JM; Pereira GN; Kobayashi RK; Nakazato G
Future Microbiol; 2020 Jun; 15():767-777. PubMed ID: 32700548
[TBL] [Abstract][Full Text] [Related]
4. [Peptides--a new strategy for combating viral infections].
Kołodziej M; Joniec J; Bartoszcze M; Mirski T; Gryko R
Przegl Epidemiol; 2011; 65(3):477-82. PubMed ID: 22184952
[TBL] [Abstract][Full Text] [Related]
5. Editorial overview: antivirals and resistance: advances and challenges ahead.
Menéndez-Arias L; Richman DD
Curr Opin Virol; 2014 Oct; 8():iv-vii. PubMed ID: 25155454
[No Abstract] [Full Text] [Related]
6. A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses.
Zheng Y; Li S; Song K; Ye J; Li W; Zhong Y; Feng Z; Liang S; Cai Z; Xu K
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632670
[TBL] [Abstract][Full Text] [Related]
7. Antivirals and antiviral strategies.
De Clercq E
Nat Rev Microbiol; 2004 Sep; 2(9):704-20. PubMed ID: 15372081
[TBL] [Abstract][Full Text] [Related]
8. Antiviral drugs: present status and future prospects.
van der Sijs IH; Wiltink EH
Int J Biochem; 1994 May; 26(5):621-30. PubMed ID: 8005347
[TBL] [Abstract][Full Text] [Related]
9. A proposed treatment for pathogenic enveloped viruses having high rates of mutation or replication.
Roe K
Scand J Immunol; 2020 Sep; 92(3):e12928. PubMed ID: 32640050
[TBL] [Abstract][Full Text] [Related]
10. Antivirals other than for HIV therapy.
Harrison CJ
Adv Pediatr; 2000; 47():335-94. PubMed ID: 10959449
[TBL] [Abstract][Full Text] [Related]
11. Current progress in antiviral strategies.
Lou Z; Sun Y; Rao Z
Trends Pharmacol Sci; 2014 Feb; 35(2):86-102. PubMed ID: 24439476
[TBL] [Abstract][Full Text] [Related]
12. Broad-Spectrum Antivirals and Antiviral Drug Combinations.
Oksenych V; Kainov DE
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215894
[TBL] [Abstract][Full Text] [Related]
13. [Combined use of antiviral preparations].
Ershov FI; Chizhov NP
Vopr Virusol; 1984; 29(6):644-56. PubMed ID: 6084895
[No Abstract] [Full Text] [Related]
14.
Ahmad G; Sohail M; Bilal M; Rasool N; Qamar MU; Ciurea C; Marceanu LG; Misarca C
Molecules; 2024 May; 29(10):. PubMed ID: 38792094
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of the formation of viral resistance to chemotherapeutic preparations].
Chizhov NP
Vopr Virusol; 1985; 30(3):266-79. PubMed ID: 3901520
[No Abstract] [Full Text] [Related]
16. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
Brooks MJ; Sasadeusz JJ; Tannock GA
Curr Opin Pulm Med; 2004 May; 10(3):197-203. PubMed ID: 15071371
[TBL] [Abstract][Full Text] [Related]
17. Thiosemicarbazides: Updates on Antivirals Strategy.
Moharana AK; Dash RN; Subudhi BB
Mini Rev Med Chem; 2020; 20(20):2135-2152. PubMed ID: 32811412
[TBL] [Abstract][Full Text] [Related]
18. Antiviral drug resistance: mechanisms and clinical implications.
Strasfeld L; Chou S
Infect Dis Clin North Am; 2010 Jun; 24(2):413-37. PubMed ID: 20466277
[TBL] [Abstract][Full Text] [Related]
19. New horizons for antiviral drug discovery from virus-host protein interaction networks.
de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
Curr Opin Virol; 2012 Oct; 2(5):606-13. PubMed ID: 23025912
[TBL] [Abstract][Full Text] [Related]
20. Antivirals: past, present and future.
De Clercq E
Biochem Pharmacol; 2013 Mar; 85(6):727-44. PubMed ID: 23270991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
